Diagnostic Accuracy of 11 COVID-19 Serological Tests
Author Information
Author(s): Zhao Ying, Zhang Minjie, Liang Weiwei, Fang Lijiang
Primary Institution: Xian Yang Central Hospital, Shaanxi University of Chinese Medicine
Hypothesis
We aimed to compare the diagnostic accuracy of 11 commercial serological assays for coronavirus disease‐2019 (COVID‐19) by taking the reverse transcriptase polymerase chain reaction (RT‐PCR) assays as the reference standard.
Conclusion
The study suggested that the Siemens SARS‐CoV‐2 total, ortho‐clinical anti‐SARS‐CoV‐2 total, and Wantai SARS‐CoV‐2 total had the best overall diagnostic accuracy.
Supporting Evidence
- The pooled DOR for assays‐based total antibody was significantly higher than for assays‐based IgG and IgM.
- Siemens SARS‐CoV‐2 total (COV2T) showed a pooled DOR of 1143.37.
- Ortho‐clinical anti‐SARS‐CoV‐2 total had a pooled DOR of 1104.60.
- Wantai SARS‐CoV‐2 total Ab had a pooled DOR of 1014.98.
- Assays‐based IgM showed lower diagnostic accuracy compared to IgG and total antibody assays.
Takeaway
This study looked at 11 different tests to see which ones are best at finding COVID-19 antibodies, and it found that some tests work better than others.
Methodology
This meta‐analysis included 57 articles and evaluated the performance of 11 serological assays using RT‐PCR as the reference standard.
Potential Biases
Some studies had unclear risk of bias due to non-blind testing and inclusion of asymptomatic or recovered patients.
Limitations
High heterogeneity among included studies and variability in methods and patient demographics.
Participant Demographics
Included COVID-19 patients and healthy controls, but specific demographics were not detailed.
Statistical Information
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website